AntriaBio

Investors

Press Releases

Jun 28, 2021 Rezolute Added to Russell Microcap® Index
May 27, 2021 Rezolute to Participate in Upcoming Virtual Healthcare Conferences
May 20, 2021 Rezolute Expands Leadership Team with the Appointment of Davelyn Hood, MD as Director, Scientific and Patient Affairs
May 18, 2021 Rezolute Appoints Leading Ophthalmology Expert, Quan Dong Nguyen, MD, MSc, FAAO, FARVO, to Scientific Advisory Board
May 17, 2021 Rezolute Reports Third Quarter Fiscal 2021 Financial Results and Highlights Recent Company Progress
May 17, 2021 Rezolute to Present at the Oppenheimer Rare and Orphan Disease Summit
May 4, 2021 Rezolute Announces Positive RZ402 Study Results Demonstrating Potential for Once Daily Dosing of an Oral Plasma Kallikrein Inhibitor for Diabetic Macular Edema
Apr 19, 2021 Rezolute Announces $30 Million Debt Financing Agreement with SLR Capital Partners
Mar 22, 2021 Rezolute Presents Data on RZ358 in Post-Gastric Bypass Hypoglycemia at ENDO 2021
Mar 8, 2021 Rezolute Strengthens Board of Directors with Key Appointments of Leading Rare Disease Experts

Show All